From the Department of Pharmacy Practice (Alatawi), Faculty of Pharmacy, University of Tabuk, Tabuk; from the Department of Natural Products and Alternative Medicine (Alshomrani, Baeshen, Alkhamisi, Almazrui, Alghamdi, Alkhilaiwi), Faculty of Pharmacy, King Abdulaziz University; from the Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer (Bugshan), King Abdulaziz University; from the Department of Radiology (Hijazi, Alahmadi, Ashoor), Faculty of Medicine, King Abdulaziz University Hospital; from the Regenerative Medicine Unit (Alkhilaiwi), King Fahd Medical Research Center; King Abdulaziz University, Jeddah; from the Computer Science Department (Alafif), Jamoum University College, Umm Al-Qura University, Jamoum; from the Department of Clinical Laboratory Sciences (Alamri), College of Applied Medical Sciences, King Khalid University; from the Cancer Research Unit (Alamri), King Khalid University, Abha, Kingdom of Saudi Arabia.
Saudi Med J. 2022 Nov;43(11):1260-1264. doi: 10.15537/smj.2022.43.11.20220269.
To evaluate early performance indicators for breast cancer screening at the King Abdulaziz University Hospital in Saudi Arabia.
This study retrospectively evaluated data from women who underwent their first breast cancer screening program in Jeddah, Saudi Arabia between 2012 and 2019. Data on screening results were used to estimate performance indicators and generate descriptive statistics.
Of the 16000 women invited from 2012 to 2019, a total of 1911 (11.9%) participated. The majority of women (68.8%) were between 40 and 55 years old. Based on the screening process results, 26.6%, 40.1%, 9.7%, 1.3%, 0.7%, and 5.2% of women had BI-RADS scores of R1, R2, R3, R4, R5, and R0 respectively. The remaining 16.3% did not have mammogram records. The recall rate, or the percentage of women who underwent further evaluation, was 19.9%; 18.9% underwent a biopsy procedure. In addition, 1.6% of women had cancer screen-detected, although only 0.7% were diagnosed with breast cancer.
In light of the low participation and high recall rates, it is essential that the screening program utilizes performance indicators to optimize resource utilization and ensure the quality of the service provided. Additionally, a national framework and standardized performance indicators could mitigate this problem for other cancer screening programs.
评估沙特阿拉伯阿卜杜勒阿齐兹国王大学医院乳腺癌筛查的早期绩效指标。
本研究回顾性评估了 2012 年至 2019 年期间在沙特阿拉伯吉达接受首次乳腺癌筛查计划的女性的数据。使用筛查结果数据来估计绩效指标并生成描述性统计数据。
在 2012 年至 2019 年期间,共邀请了 16000 名女性,共有 1911 名(11.9%)参加。大多数女性(68.8%)年龄在 40 至 55 岁之间。根据筛查过程的结果,26.6%、40.1%、9.7%、1.3%、0.7%和 5.2%的女性的 BI-RADS 评分分别为 R1、R2、R3、R4、R5 和 R0。其余 16.3%的女性没有乳房 X 光记录。召回率,即接受进一步评估的女性比例为 19.9%;18.9%的女性接受了活检程序。此外,1.6%的女性癌症筛查发现,但只有 0.7%被诊断为乳腺癌。
鉴于参与率低和召回率高,筛查计划必须利用绩效指标来优化资源利用并确保提供服务的质量。此外,国家框架和标准化的绩效指标可以为其他癌症筛查计划解决这个问题。